Preferential interactions between ApoE-containing lipoproteins and Aβ revealed by a detection method that combines size exclusion chromatography with non-reducing gel-shift

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1821, Issue 2, 2012, Pages 295-302

  Ladu, Mary Jo ^a   Munson, Gregory W ^b,c   Jungbauer, Lisa ^a,d   Getz, Godfrey S ^b   Reardon, Catherine A ^b   Tai, Leon M ^a   Yu, Chunjiang ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c Northwest Gastroenterology   (United States)

^d MEDTRONIC INC   (United States)

Author keywords

Alzheimer's disease; Amyloid beta peptide (A ); apoE A ; Apolipoprotein E (apoE); Interaction; Lipoprotein

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; BLOOD; CEREBROSPINAL FLUID; CONTROLLED STUDY; GEL PERMEATION CHROMATOGRAPHY; HUMAN; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN HOMEOSTASIS; PROTEIN INTERACTION; RAT; STANDARDIZATION;

AMYLOID BETA-PEPTIDES; ANIMALS; APOLIPOPROTEINS E; ASTROCYTES; CHROMATOGRAPHY, GEL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; LIPOPROTEINS; LIPOPROTEINS, HDL; PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY;

EID: 83655169782     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2011.11.005     Document Type: Article

References (66)

1. E.H. Corder, A.M. Saunders, W.J. Strittmatter, D.E. Schmechel, P.C. Gaskell, G.W. Small, A.D. Roses, J.L. Haines, and M.A. Pericak-Vance Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families Science 261 1993 921 923 (Pubitemid 23275809)
2. E.H. Corder, S.M. Saunder, N.J. Risch, W.J. Strittmatter, D.E. Schmechel, P.C. Gaskell Jr., J.B. Rimmler, P.A. Locke, P.M. Conneally, K.E. Schmader, G.W. Small, A.D. Roses, J.L. Haines, and M.A. Pericak-Vance Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease Nat. Genet. 7 1994 180 184 (Pubitemid 24174658)
3. L. Bertram, M.B. McQueen, K. Mullin, D. Blacker, and R.E. Tanzi Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database Nat. Genet. 39 2007 17 23 (Pubitemid 46026496)
4. D.A. Elliott, C.S. Weickert, and B. Garner Apolipoproteins in the brain: implications for neurological and psychiatric disorders J. Clin. Lipidol. 51 2010 555 573
5. Q. Xu, A. Bernardo, D. Walker, T. Kanegawa, R.W. Mahley, and Y. Huang Profile and regulation of apolipoprotein E (ApoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the ApoE locus J. Neurosci. 26 2006 4985 4994 (Pubitemid 44315280)
6. C. Yu, K.L. Youmans, and M.J. Ladu Proposed mechanism for lipoprotein remodelling in the brain Biochim. Biophys. Acta 1801 2010 819 823
7. P.S. Hauser, V. Narayanaswami, and R.O. Ryan Apolipoprotein E: from lipid transport to neurobiology Prog. Lipid Res. 50 2011 62 74
8. P. Seubert, C. Vigo-Pelfrey, F. Esch, M. Lee, H. Dovey, D. Davis, S. Sinha, M. Schiossmacher, J. Whaley, C. Swindlehurst, R. McCormack, R. Wolfert, D. Selkoe, I. Lieberburg, and D. Schenk Isolation and quantification of soluble Alzheimer's [beta]-peptide from biological fluids Nature 359 1992 325 327
9. A. Koudinov, E. Matsubara, B. Frangione, and J. Ghiso The soluble form of Alzheimer's amyloid beta protein is complexed to high density lipoprotein 3 and very high density lipoprotein in normal human plasma Biochem. Biophys. Res. Commun. 205 1994 1164 1171
10. \A.L. Biere, B. Ostaszewski, E.R. Stimson, B.T. Hyman, J.E. Maggio, and D.J. Selkoe Amyloid beta-peptide is transported on lipoproteins and albumin in human plasma J. Biol. Chem. 271 1996 32916 32922 (Pubitemid 27008725)
11. H. Scharnagl, U. Tisljar, K. Winkler, M. Huttinger, M.A. Nauck, W. Gross, H. Wieland, T.G. Ohm, and W. Marz The betaA4 amyloid peptide complexes to and enhances the uptake of beta-very low density lipoproteins by the low density lipoprotein receptor-related protein and heparan sulfate proteoglycans pathway Lab. Invest. 79 1999 1271 1286 (Pubitemid 29489451)
12. A.R. Koudinov, T.T. Berezov, A. Kumar, and N.V. Koudinova Alzheimer's amyloid beta interaction with normal human plasma high density lipoprotein: association with apolipoprotein and lipids Clin. Chim. Acta 270 1998 75 84 (Pubitemid 28095681)
13. B. Permanne, C. Perez, C. Soto, B. Frangione, and T. Wisniewski Detection of apolipoprotein E/dimeric soluble amyloid ß complexes in Alzheimer's disease brain supernatants Biochem. Biophys. Res. Commun. 240 1997 715 720 (Pubitemid 28271784)
14. J. Ghiso, E. Matsubara, A. Koudinov, N.H. Choi-Miura, M. Tomita, T. Wisniewski, and B. Frangione The cerebrospinal-fluid form of Alzheimer's amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex Biochem. J. 293 1993 27 30 (Pubitemid 23223142)
15. A.R. Koudinov, T.T. Berezov, and N.V. Koudinova The levels of soluble amyloid beta in different high density lipoprotein subfractions distinguish Alzheimer's and normal aging cerebrospinal fluid: implication for brain cholesterol pathology? Neurosci. Lett. 314 2001 115 118 (Pubitemid 33043780)
16. A.R. Koudinov, N.V. Koudinova, A. Kumar, R.C. Beavis, and J. Ghiso Biochemical characterization of Alzheimer's soluble amyloid beta protein in human cerebrospinal fluid: association with high density lipoproteins Biochem. Biophys. Res. Commun. 223 1996 592 597 (Pubitemid 26246118)
17. A.M. Fagan, L.H. Younkin, J.C. Morris, J.D. Fryer, T.G. Cole, S.G. Younkin, and D.M. Holtzman Differences in the Abeta40/Abeta42 ratio associated with cerebrospinal fluid lipoproteins as a function of apolipoprotein E genotype Ann. Neurol. 48 2000 201 210 (Pubitemid 30617039)
18. A. Sagare, R. Deane, R.D. Bell, B. Johnson, K. Hamm, R. Pendu, A. Marky, P.J. Lenting, Z. Wu, T. Zarcone, A. Goate, K. Mayo, D. Perlmutter, M. Coma, Z. Zhong, and B.V. Zlokovic Clearance of amyloid-beta by circulating lipoprotein receptors Nat. Med. 13 2007 1029 1031 (Pubitemid 47517512)
19. E. Matsubara, Y. Sekijima, T. Tokuda, K. Urakami, M. Amari, M. Shizuka-Ikeda, Y. Tomidokoro, M. Ikeda, T. Kawarabayashi, Y. Harigaya, S. Ikeda, T. Murakami, K. Abe, E. Otomo, S. Hirai, B. Frangione, J. Ghiso, and M. Shoji Soluble Abeta homeostasis in AD and DS: impairment of anti-amyloidogenic protection by lipoproteins Neurobiol. Aging 25 2004 833 841 (Pubitemid 38813163)
20. J.C. Mamo, L. Jian, A.P. James, L. Flicker, H. Esselmann, J. Wiltfang, and J.C.L. Mamo Plasma lipoprotein beta-amyloid in subjects with Alzheimer's disease or mild cognitive impairment Ann. Clin. Biochem. 45 2008 395 403 (Pubitemid 352031547)
21. A.R. Koudinov, N.V. Koudinova, T.T. Berezov, and Y.D. Ivanov HDL phospholipid: a natural inhibitor of Alzheimer's amyloid beta-fibrillogenesis? Clin. Chem. Lab. Med. 37 1999 993 994 (Pubitemid 30011580)
22. G.M. Cole, W. Beech, S.A. Frautschy, J. Sigel, C. Glasgow, and M.D. Ard Lipoprotein effects on Abeta accumulation and degradation by microglia in vitro J. Neurosci. Res. 57 1999 504 520 (Pubitemid 29372925)
23. M.J. LaDu, M.T. Falduto, A.M. Manelli, C.A. Reardon, G.S. Getz, and D.E. Frail Isoform-specific binding of apolipoprotein E to beta-amyloid J. Biol. Chem. 269 1994 23403 23406
24. M.J. LaDu, T.M. Pederson, D.E. Frail, C.A. Reardon, G.S. Getz, and M.T. Falduto Purification of apolipoprotein E attenuates isoform-specific binding to beta-amyloid J. Biol. Chem. 270 1995 9039 9042
25. M.J. LaDu, J.R. Lukens, C.A. Reardon, and G.S. Getz Association of human, rat, and rabbit apolipoprotein E with beta-amyloid J. Neurosci. Res. 49 1997 9 18 (Pubitemid 27291172)
26. T. Tokuda, M. Calero, E. Matsubara, R. Vidal, A. Kumar, B. Permanne, B. Zlokovic, J.D. Smith, M.J. Ladu, A. Rostagno, B. Frangione, and J. Ghiso Lipidation of apolipoprotein E influences its isoform-specific interaction with Alzheimer's amyloid beta peptides Biochem. J. 348 Pt 2 2000 359 365 (Pubitemid 30345209)
27. N.M. Bentley, M.J. Ladu, C. Rajan, G.S. Getz, and C.A. Reardon Apolipoprotein E structural requirements for the formation of SDS-stable complexes with beta-amyloid-(1-40): the role of salt bridges Biochem. J. 366 2002 273 279 (Pubitemid 34971827)
28. M. Morikawa, J.D. Fryer, P.M. Sullivan, E.A. Christopher, S.E. Wahrle, R.B. DeMattos, M.A. O'Dell, A.M. Fagan, H.A. Lashuel, T. Walz, K. Asai, and D.M. Holtzman Production and characterization of astrocyte-derived human apolipoprotein E isoforms from immortalized astrocytes and their interactions with amyloid-beta Neurobiol. Dis. 19 2005 66 76 (Pubitemid 40544724)
29. W.J. Strittmatter, A.M. Saunders, D. Schmechel, M. Pericak-Vance, J. Enghild, G.S. Salvesen, and A.D. Roses Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease Proc. Natl. Acad. Sci. U.S.A. 90 1993 1977 1981 (Pubitemid 23069980)
30. M.J. LaDu, S.M. Gilligan, J.R. Lukens, V.G. Cabana, C.A. Reardon, L.J. Van Eldik, and D.M. Holtzman Nascent astrocyte particles differ from lipoproteins in CSF J. Neurochem. 70 1998 2070 2081 (Pubitemid 28207831)
31. C. Russo, G. Angelini, D. Dapino, A. Piccini, G. Piombo, G. Schettini, S. Chen, J.K. Teller, D. Zaccheo, P. Gambetti, and M. Tabaton Opposite roles of apolipoprotein E in normal brains and in Alzheimer's disease Proc. Natl. Acad. Sci. U.S.A. 95 1998 15598 15602 (Pubitemid 29018745)
32. A.A. Golabek, C. Soto, T. Vogel, and T. Wisniewski The interaction between apolipoprotein E and Alzheimer's amyloid ß-peptide is dependent on ß-peptide conformation J. Biol. Chem. 271 1996 10602 10606
33. T. Pillot, M. Goethals, B. Vanloo, L. Lins, R. Brasseur, J. Vandekerckhove, and M. Rosseneu Specific modulation of the fusogenic properties of the Alzheimer beta-amyloid peptide by apolipoprotein E isoforms Eur. J. Biochem. 243 1997 650 659 (Pubitemid 27073431)
34. T. Pillot, M. Goethals, J. Najib, C. Labeur, L. Lins, J. Chambaz, R. Brasseur, J. Vandekerckhove, and M. Rosseneu Beta-amyloid peptide interacts specifically with the carboxy-terminal domain of human apolipoprotein E: relevance to Alzheimer's disease J. Neurochem. 72 1999 230 237 (Pubitemid 29013897)
35. K. Yamauchi, M. Tozuka, H. Hidaka, T. Nakabayashi, M. Sugano, Y. Kondo, A. Nakagawara, and T. Katsuyama Effect of apolipoprotein AII on the interaction of apolipoprotein E with beta-amyloid: some apo(E-AII) complexes inhibit the internalization of beta-amyloid in cultures of neuroblastoma cells J. Neurosci. Res. 62 2000 608 614
36. A.M. Fagan, D.M. Holtzman, G. Munson, T. Mathur, D. Schneider, L.K. Chang, G.S. Getz, C.A. Reardon, J. Lukens, J.A. Shah, and M.J. LaDu Unique lipoproteins secreted by primary astrocytes from wild type, apoE (-/-), and human apoE transgenic mice J. Biol. Chem. 274 1999 30001 30007
37. R.B. DeMattos, R.P. Brendza, J.E. Heuser, M. Kierson, J.R. Cirrito, J. Fryer, P.M. Sullivan, A.M. Fagan, X. Han, and D.M. Holtzman Purification and characterization of astrocyte-secreted apolipoprotein E and J-containing lipoproteins from wild-type and human apoE transgenic mice Neurochem. Int. 39 2001 415 425 (Pubitemid 32907406)
38. S. Koch, N. Donarski, K. Goetze, M. Kreckel, H.J. Stuerenburg, C. Buhmann, and U. Beisiegel Characterization of four lipoprotein classes in human cerebrospinal fluid J. Lipid Res. 42 2001 1143 1151 (Pubitemid 32645797)
39. G.R. Castro, and C.J. Fielding Evidence for the distribution of apolipoprotein E between lipoprotein classes in human normocholesterolemic plasma and for the origin of unassociated apolipoprotein E (Lp-E) J. Lipid Res. 25 1984 58 67 (Pubitemid 14150294)
40. R.M. Corbo, and R. Scacchi Apolipoprotein E (APOE) allele distribution in the world. Is APOE*4 a 'thrifty' allele? Ann. Hum. Genet. 63 1999 301 310 (Pubitemid 30021229)
41. M. Folin, S. Baiguera, M.T. Conconi, R. Di Liddo, E. De Carlo, P.P. Parnigotto, and G.G. Nussdorfer Apolipoprotein E as vascular risk factor in neurodegenerative dementia Int. J. Mol. Med. 14 2004 609 613
42. S.P. Mooijaart, P. van Vliet, D. van Heemst, P.C. Rensen, J.F. Berbee, J. Jolles, A.J. de Craen, and R.G. Westendorp Plasma levels of apolipoprotein E and cognitive function in old age Ann. N. Y. Acad. Sci. 1100 2007 148 161 (Pubitemid 47092647)
43. F. Panza, V. Solfrizzi, A.M. Colacicco, A.M. Basile, A. D'Introno, C. Capurso, M. Sabba, S. Capurso, and A. Capurso Apolipoprotein E (APOE) polymorphism influences serum APOE levels in Alzheimer's disease patients and centenarians Neuroreport 14 2003 605 608 (Pubitemid 36528999)
44. G. Siest, P. Bertrand, B. Qin, B. Herbeth, J.M. Serot, L. Masana, J. Ribalta, A.P. Passmore, A. Evans, M. Ferrari, M. Franceschi, J. Shepherd, M. Cuchel, U. Beisiegel, K. Zuchowsky, A.S. Rukavina, J. Sertic, M. Stojanov, V. Kostic, A. Mitrevski, V. Petrova, C. Sass, A. Merched, J.T. Salonen, L. Tiret, and S. Visvikis Apolipoprotein E polymorphism and serum concentration in Alzheimer's disease in nine European centres: the ApoEurope study. ApoEurope group Clin. Chem. Lab. Med. 38 2000 721 730
45. A.J. Slooter, M.X. Tang, C.M. van Duijn, Y. Stern, A. Ott, K. Bell, M.M. Breteler, C. Van Broeckhoven, T.K. Tatemichi, B. Tycko, A. Hofman, and R. Mayeux Apolipoprotein E epsilon4 and the risk of dementia with stroke. A population-based investigation JAMA 277 1997 818 821 (Pubitemid 27111318)
46. P. van Vliet, S.P. Mooijaart, A.J. de Craen, P.C. Rensen, D. van Heemst, and R.G. Westendorp Plasma levels of apolipoprotein E and risk of stroke in old age Ann. N. Y. Acad. Sci. 1100 2007 140 147 (Pubitemid 47092646)
47. P. van Vliet, A.M. Oleksik, S.P. Mooijaart, A.J. de Craen, and R.G. Westendorp APOE genotype modulates the effect of serum calcium levels on cognitive function in old age Neurology 72 2009 821 828
48. P. Lichtlen, and M.H. Mohajeri Antibody-based approaches in Alzheimer's research: safety, pharmacokinetics, metabolism, and analytical tools J. Neurochem. 104 2008 859 874 (Pubitemid 351143651)
49. K. Yaffe, A. Weston, N.R. Graff-Radford, S. Satterfield, E.M. Simonsick, S.G. Younkin, L.H. Younkin, L. Kuller, H.N. Ayonayon, J. Ding, and T.B. Harris Association of plasma beta-amyloid level and cognitive reserve with subsequent cognitive decline JAMA 305 2011 261 266
50. J. Carlsson, V.W. Armstrong, H. Reiber, K. Felgenhauer, and D. Seidel Clinical relevance of the quantification of apolipoprotein E in cerebrospinal fluid Clin. Chim. Acta 196 1991 167 176
51. C. Hesse, H. Larsson, P. Fredman, L. Minthon, N. Andreasen, P. Davidsson, and K. Blennow Measurement of apolipoprotein E (apoE) in cerebrospinal fluid Neurochem. Res. 25 2000 511 517 (Pubitemid 30317684)
52. S.E. Wahrle, A.R. Shah, A.M. Fagan, S. Smemo, J.S. Kauwe, A. Grupe, A. Hinrichs, K. Mayo, H. Jiang, L.J. Thal, A.M. Goate, and D.M. Holtzman Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1 polymorphisms Mol. Neurodegener. 2 2007 7
53. M.J. LaDu, W.B. Stine Jr., M. Narita, G.S. Getz, C.A. Reardon, and G. Bu Self-assembly of HEK cell-secreted ApoE particles resembles ApoE enrichment of lipoproteins as a ligand for the LDL receptor-related protein Biochemistry 45 2006 381 390 (Pubitemid 43100405)
54. A.M. Manelli, W.B. Stine, L.J. Van Eldik, and M.J. LaDu ApoE and Abeta1-42 interactions: effects of isoform and conformation on structure and function J. Mol. Neurosci. 23 2004 235 246
55. M.J. Ladu, C. Reardon, L. Van Eldik, A.M. Fagan, G. Bu, D. Holtzman, and G.S. Getz Lipoproteins in the central nervous system Ann. N. Y. Acad. Sci. 903 2000 167 175 (Pubitemid 30251555)
56. J. Kim, J.M. Basak, and D.M. Holtzman The role of apolipoprotein E in Alzheimer's disease Neuron 63 2009 287 303
57. Y. Sun, S. Wu, G. Bu, M.K. Onifade, S.N. Patel, M.J. LaDu, A.M. Fagan, and D.M. Holtzman Glial fibrillary acidic protein-apolipoprotein E (apoE) transgenic mice: astrocyte-specific expression and differing biological effects of astrocyte-secreted apoE3 and apoE4 lipoproteins J. Neurosci. 18 1998 3261 3272 (Pubitemid 28186019)
58. K. Blennow, H. Hampel, M. Weiner, and H. Zetterberg Cerebrospinal fluid and plasma biomarkers in Alzheimer disease Nat. Rev. Neurol. 6 2010 131 144
59. J.K. Lui, S.M. Laws, Q.X. Li, V.L. Villemagne, D. Ames, B. Brown, A.I. Bush, K. De Ruyck, J. Dromey, K.A. Ellis, N.G. Faux, J. Foster, C. Fowler, V. Gupta, P. Hudson, K. Laughton, C.L. Masters, K. Pertile, A. Rembach, M. Rimajova, M. Rodrigues, C.C. Rowe, R. Rumble, C. Szoeke, K. Taddei, T. Taddei, B. Trounson, V. Ward, R.N. Martins, and A.R. Group Plasma amyloid-beta as a biomarker in Alzheimer's disease: the AIBL study of aging J. Alzheimers Dis. 20 2010 1233 1242
60. N.R. Graff-Radford, J.E. Crook, J. Lucas, B.F. Boeve, D.S. Knopman, R.J. Ivnik, G.E. Smith, L.H. Younkin, R.C. Petersen, and S.G. Younkin Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease Arch. Neurol. 64 2007 354 362 (Pubitemid 46425689)
61. K. Yanagisawa, A. Odaka, N. Suzuki, and Y. Ihara GM1 ganglioside-bound amyloid beta-protein (A beta): a possible form of preamyloid in Alzheimer's disease Nat. Med. 1 1995 1062 1066
62. J. McLaurin, and A. Chakrabartty Membrane disruption by Alzheimer beta-amyloid peptides mediated through specific binding to either phospholipids or gangliosides. Implications for neurotoxicity J. Biol. Chem. 271 1996 26482 26489 (Pubitemid 26359045)
63. H. Hayashi, N. Kimura, H. Yamaguchi, K. Hasegawa, T. Yokoseki, M. Shibata, N. Yamamoto, M. Michikawa, Y. Yoshikawa, K. Terao, K. Matsuzaki, C.A. Lemere, D.J. Selkoe, H. Naiki, and K. Yanagisawa A seed for Alzheimer amyloid in the brain J. Neurosci. 24 2004 4894 4902 (Pubitemid 38668215)
64. S.A. Waschuk, E.A. Elton, A.A. Darabie, P.E. Fraser, and J.A. McLaurin Cellular membrane composition defines A beta-lipid interactions J. Biol. Chem. 276 2001 33561 33568
65. L. Cai, M.C. de Beer, F.C. de Beer, and D.R. van der Westhuyzen Serum amyloid A is a ligand for scavenger receptor SR-BI and inhibits HDL binding and selective lipid uptake J. Biol. Chem. 280 2004 2954 2961 (Pubitemid 40189405)
66. M. Mulder, and D. Terwel Possible link between lipid metabolism and cerebral amyloid angiopathy in Alzheimer's disease: a role for high-density lipoproteins? Haemostasis 28 1998 174 194 (Pubitemid 29309599)